This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection (PADA-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03079011
Recruitment Status : Active, not recruiting
First Posted : March 14, 2017
Last Update Posted : September 22, 2023
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
UNICANCER

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : April 30, 2021
Estimated Study Completion Date : June 30, 2025